ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

January 28, 2011

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

In Brief: white House Names Phillip Sharp To NCAB; Shine Re-appointed As IOM President

September 27, 1996

Emory Executive Objects to Report On Merit review

July 22, 1977

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

In Brief: Ed Moorhead, Community Cancer program Leader, Dies At Age 50; Ficca Appointed NHLBI AO

February 6, 1987